A premium premium

Totting up investors' multiples on Allergan's acquisition of NASH play Tobira

The acquisition of Tobira Therapeutics Inc. (NASDAQ:TBRA) by Allergan plc (NYSE:AGN) suggests significant value exists for investors willing to sift through clinical trials that produce less than clear-cut results. In this case, long-time Tobira holders, as well as some new entrants that parsed a failed Phase II study in non-alcoholic

Read the full 506 word article

How to gain access

Continue reading with a
two-week free trial.